Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Carey, Lisa A, Berry, Donald A, Cirrincione, Constance T, Barry, William T, Pitcher, Brandelyn N, Harris, Lyndsay N, Ollila, David W, Krop, Ian E, Henry, Norah Lynn, Weckstein, Douglas J, Anders, Carey K, Singh, Baljit, Hoadley, Katherine A, Iglesia, Michael, Cheang, Maggie Chon U, Perou, Charles M, Winer, Eric P, Hudis, Clifford A
Published in Journal of clinical oncology (20.02.2016)
Published in Journal of clinical oncology (20.02.2016)
Get full text
Journal Article
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
HURRIA, Arti, CIRRINCIONE, Constance T, KIRSHNER, Jeffrey, TOGAWA, Kayo, HANSEN, Kurt, KATHERIA, Vani, STONE, Richard, GALINSKY, Ilene, POSTIGLIONE, John, JAY COHEN, Harvey, MUSS, Hyman B, KORNBLITH, Alice B, BARRY, William, ARTZ, Andrew S, SCHMIEDER, Linda, ANSARI, Rafat, TEW, William P, WECKSTEIN, Douglas
Published in Journal of clinical oncology (01.04.2011)
Published in Journal of clinical oncology (01.04.2011)
Get full text
Journal Article
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
Basch, Ethan, Dueck, Amylou C, Rogak, Lauren J, Minasian, Lori M, Kelly, William Kevin, O'Mara, Ann M, Denicoff, Andrea M, Seisler, Drew, Atherton, Pamela J, Paskett, Electra, Carey, Lisa, Dickler, Maura, Heist, Rebecca S, Himelstein, Andrew, Rugo, Hope S, Sikov, William M, Socinski, Mark A, Venook, Alan P, Weckstein, Douglas J, Lake, Diana E, Biggs, David D, Freedman, Rachel A, Kuzma, Charles, Kirshner, Jeffrey J, Schrag, Deborah
Published in JAMA oncology (01.08.2017)
Published in JAMA oncology (01.08.2017)
Get more information
Journal Article
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
Lipsyc-Sharf, Marla, Ou, Fang-Shu, Yurgelun, Matthew B, Rubinson, Douglas A, Schrag, Deborah, Dakhil, Shaker R, Stella, Philip J, Weckstein, Douglas J, Wender, Donald B, Faggen, Meredith, Zemla, Tyler J, Heying, Erica N, Schuetz, Samantha R, Noble, Stephanie, Meyerhardt, Jeffrey A, Bekaii-Saab, Tanios, Fuchs, Charles S, Ng, Kimmie
Published in The oncologist (Dayton, Ohio) (05.04.2022)
Published in The oncologist (Dayton, Ohio) (05.04.2022)
Get full text
Journal Article
Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer
Nakabayashi, Mari, Werner, Lilian, Courtney, Kevin D., Buckle, Geoffrey, Oh, William K., Bubley, Glen J., Hayes, Julia H., Weckstein, Douglas, Elfiky, Aymen, Sims, Danny M., Kantoff, Philip W., Taplin, Mary‐Ellen
Published in BJU international (01.12.2012)
Published in BJU international (01.12.2012)
Get full text
Journal Article
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Barroso-Sousa, Romualdo, Tarantino, Paolo, Tayob, Nabihah, Dang, Chau, Yardley, Denise A., Isakoff, Steven J., Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Hu, Jiani, Weckstein, Douglas, Wolff, Antonio C., Reeder-Hayes, Katherine, Rugo, Hope S., Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit, Briccetti, Frederick, Schneider, Bryan, Garrett, Audrey Merrill, Marcom, Kelly, Albain, Kathy, DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel C., Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R., Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta, Ruddy, Kathryn J., Zheng, Yue, Rosenberg, Shoshana M., Gelber, Richard D., Trippa, Lorenzo, Barry, William, DeMeo, Michelle, Burstein, Harold, Partridge, Ann, Winer, Eric P., Krop, Ian, Tolaney, Sara M.
Published in NPJ breast cancer (16.02.2022)
Published in NPJ breast cancer (16.02.2022)
Get full text
Journal Article
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Ng, Kimmie, Nimeiri, Halla S, McCleary, Nadine J, Abrams, Thomas A, Yurgelun, Matthew B, Cleary, James M, Rubinson, Douglas A, Schrag, Deborah, Miksad, Rebecca, Bullock, Andrea J, Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A, Wolpin, Brian M, Constantine, Michael, Weckstein, Douglas J, Faggen, Meredith A, Thomas, Christian A, Kournioti, Chryssanthi, Yuan, Chen, Ganser, Christine, Wilkinson, Brittney, Mackintosh, Christopher, Zheng, Hui, Hollis, Bruce W, Meyerhardt, Jeffrey A, Fuchs, Charles S
Published in JAMA : the journal of the American Medical Association (09.04.2019)
Published in JAMA : the journal of the American Medical Association (09.04.2019)
Get full text
Journal Article
Effect of High-Dose vs Standard-Dose Vitamin D 3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Brown, Justin C, Rosenthal, Michael H, Ma, Chao, Zhang, Sui, Nimeiri, Halla S, McCleary, Nadine J, Abrams, Thomas A, Yurgelun, Matthew B, Cleary, James M, Rubinson, Douglas A, Schrag, Deborah, Bullock, Andrea J, Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A, Wolpin, Brian, Constantine, Michael, Weckstein, Douglas J, Faggen, Meredith A, Thomas, Christian A, Kournioti, Chryssanthi, Yuan, Chen, Zheng, Hui, Hollis, Bruce W, Fuchs, Charles S, Ng, Kimmie, Meyerhardt, Jeffrey A
Published in Cancers (20.11.2020)
Published in Cancers (20.11.2020)
Get full text
Journal Article
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Brown, Justin C., Rosenthal, Michael H., Ma, Chao, Zhang, Sui, Nimeiri, Halla S., McCleary, Nadine J., Abrams, Thomas A., Yurgelun, Matthew B., Cleary, James M., Rubinson, Douglas A., Schrag, Deborah, Bullock, Andrea J., Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A., Wolpin, Brian, Constantine, Michael, Weckstein, Douglas J., Faggen, Meredith A., Thomas, Christian A., Kournioti, Chryssanthi, Yuan, Chen, Zheng, Hui, Hollis, Bruce W., Fuchs, Charles S., Ng, Kimmie, Meyerhardt, Jeffrey A.
Published in Cancers (20.11.2020)
Published in Cancers (20.11.2020)
Get full text
Journal Article
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial
Himelstein, Andrew L, Foster, Jared C, Khatcheressian, James L, Roberts, John D, Seisler, Drew K, Novotny, Paul J, Qin, Rui, Go, Ronald S, Grubbs, Stephen S, O’Connor, Tracey, Velasco, Mario R, Weckstein, Douglas, O’Mara, Ann, Loprinzi, Charles L, Shapiro, Charles L
Published in JAMA : the journal of the American Medical Association (03.01.2017)
Published in JAMA : the journal of the American Medical Association (03.01.2017)
Get full text
Journal Article
Effect of High-Dose vs Standard-Dose Vitamin D 3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Ng, Kimmie, Nimeiri, Halla S., McCleary, Nadine J., Abrams, Thomas A., Yurgelun, Matthew B., Cleary, James M., Rubinson, Douglas A., Schrag, Deborah, Miksad, Rebecca, Bullock, Andrea J., Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A., Wolpin, Brian M., Constantine, Michael, Weckstein, Douglas J., Faggen, Meredith A., Thomas, Christian A., Kournioti, Chryssanthi, Yuan, Chen, Ganser, Christine, Wilkinson, Brittney, Mackintosh, Christopher, Zheng, Hui, Hollis, Bruce W., Meyerhardt, Jeffrey A., Fuchs, Charles S.
Published in JAMA : the journal of the American Medical Association (09.04.2019)
Published in JAMA : the journal of the American Medical Association (09.04.2019)
Get full text
Journal Article
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Tolaney, Sara M, Tayob, Nabihah, Dang, Chau, Yardley, Denise A, Isakoff, Steven J, Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Hu, Jiani, Weckstein, Douglas, Wolff, Antonio C, Reeder-Hayes, Katherine, Rugo, Hope S, Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K, Constantine, Michael, Cheng, Kit, Briccetti, Frederick, Schneider, Bryan, Garrett, Audrey Merrill, Marcom, Kelly, Albain, Kathy, DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel C, Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R, Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta, Ruddy, Kathryn, Zheng, Yue, Rosenberg, Shoshana M, Gelber, Richard D, Trippa, Lorenzo, Barry, William, DeMeo, Michelle, Burstein, Harold, Partridge, Ann, Winer, Eric P, Krop, Ian
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Assessment of perceived cost to the patient and other barriers to clinical trial participation
Weckstein, Douglas J, Thomas, Christian A, Emery, Ivette F, Shea, Barbara F, Fleury, Alison, White, Margaret E, Chase, Elizabeth, Robinson, Cindy, Frazier, Stacey, Pilar, Christine
Published in Journal of oncology practice (01.09.2011)
Published in Journal of oncology practice (01.09.2011)
Get full text
Journal Article
Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
Aggarwal, Rahul Raj, Dooley, Katherine, Hillman, David W., Xiao, Han, Picus, Joel, Taplin, Mary-Ellen, Dorff, Tanya B., Appleman, Leonard Joseph, Weckstein, Douglas Jay, Patnaik, Akash, Bryce, Alan Haruo, Shevrin, Daniel H., Mohler, James L., Anderson, Daniel M., Heller, Glenn, Halabi, Susan, Tan, Alan, Eggener, Scott E., Ryan, Charles J., Morris, Michael J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
Aggarwal, Rahul Raj, Heller, Glenn, Hillman, David W., Xiao, Han, Picus, Joel, Taplin, Mary-Ellen, Dorff, Tanya B., Appleman, Leonard Joseph, Weckstein, Douglas Jay, Patnaik, Akash, Bryce, Alan Haruo, Shevrin, Daniel H., Mohler, James, Anderson, Daniel M., Rao, Arpit, Tagawa, Scott T., Tan, Alan, Eggener, Scott E., Ryan, Charles J., Morris, Michael J.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Aggarwal, Rahul, Heller, Glenn, Hillman, David W, Xiao, Han, Picus, Joel, Taplin, Mary-Ellen, Dorff, Tanya, Appleman, Leonard, Weckstein, Douglas, Patnaik, Akash, Bryce, Alan, Shevrin, Daniel, Mohler, James, Anderson, Daniel, Rao, Arpit, Tagawa, Scott, Tan, Alan, Halabi, Susan, Dooley, Katharine, O'Brien, Patrick, Chen, Ronald, Ryan, Charles J, Eggener, Scott E, Morris, Michael J
Published in Journal of clinical oncology (01.04.2024)
Published in Journal of clinical oncology (01.04.2024)
Get full text
Journal Article
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
Ruddy, Kathryn J., Zheng, Yue, Tayob, Nabihah, Hu, Jiani, Dang, Chau T., Yardley, Denise A., Isakoff, Steven J., Valero, Vicente V., Faggen, Meredith G., Mulvey, Therese M., Bose, Ron, Sella, Tal, Weckstein, Douglas J., Wolff, Antonio C., Reeder-Hayes, Katherine E., Rugo, Hope S., Ramaswamy, Bhuvaneswari, Zuckerman, Dan S., Hart, Lowell L., Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit L., Briccetti, Frederick M., Schneider, Bryan P., Merrill Garrett, A., Kelly Marcom, P., Albain, Kathy S., DeFusco, Patricia A., Tung, Nadine M., Ardman, Blair M., Nanda, Rita, Jankowitz, Rachel C., Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R., Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta C., Rosenberg, Shoshana, DeMeo, Michelle K., Burstein, Harold J., Winer, Eric P., Krop, Ian E., Partridge, Ann H., Tolaney, Sara M.
Published in Breast cancer research and treatment (01.08.2021)
Published in Breast cancer research and treatment (01.08.2021)
Get full text
Journal Article
Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC)
Liu, Minetta C., Hillman, David W., Frith, Ashley Elizabeth, Lyss, Alan P., Weckstein, Douglas Jay, Moreno-Aspitia, Alvaro, Le-Lindqwister, Nguyet, Isaacs, Claudine, Wender, Donald B., Lewis, DeQuincy Andrew, Cole, John T., Jaslowski, Anthony John, Rowland, Kendrith M., Openshaw, Thomas H., Friday, Bret Edward Buckley, Fleming, Gini F., Asmus, Erik, Rogak, Lauren J., Basch, Ethan M., Dueck, Amylou C.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Irinotecan, cetuximab, and bevacizumab (CBI) versus irinotecan, cetuximab, and placebo (CI) in irinotecan-refractory metastatic colorectal cancer (mCRC): Results from an ACCRU network randomized phase II trial
Lipsyc-Sharf, Marla, Ou, Fang-Shu, Yurgelun, Matthew B., Rubinson, Douglas Adam, Schrag, Deborah, Dakhil, Shaker R., Stella, Philip J., Weckstein, Douglas Jay, Wender, Donald B., Faggen, Meredith Gail, Zemla, Tyler, Heying, Erica N., Schuetz, Samantha R, Noble, Stephanie, Meyerhardt, Jeffrey A., Bekaii-Saab, Tanios S., Fuchs, Charles S., Ng, Kimmie
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Abstract GS1-05: TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT)
Tolaney, Sara M, Trippa, Lorenzo, Barry, William, Hu, Jiani, Dang, Chau, Yardley, Denise, Isakoff, Steven, Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Weckstein, Douglas, Wolff, Antonio, Reeder-Hayes, Katherine, Rugo, Hope, Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit, Briccetti, Frederick, Schneider, Bryan, Garrett, Merrill, Marcom, Kelly, Albain, Kathy, DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel, Demeo, Michelle, Partridge, Ann, Burstein, Harold, Winer, Eric P., Krop, Ian
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article